ChemFeeds Site Navigation:
Journal Selection:
Search:

99) LNA-i-miR-221 Inhibitor Overcomes Melphalan Resistance (Clinical Cancer Research) Tuesday March 1st 2016


100) Combined Apoptosis Induction of ATRA with Sorafenib in AML (Clinical Cancer Research) Tuesday March 1st 2016


101) Mithramycin and MPM (Clinical Cancer Research) Tuesday March 1st 2016


102) Preclinical Efficacy of RG7112 in Glioblastoma (Clinical Cancer Research) Tuesday March 1st 2016


103) Synergistic Antitumor Effect of RFA and PD-1 Blockade (Clinical Cancer Research) Tuesday March 1st 2016


104) Radiation and Vaccination Reverse Tolerance to CNS Melanoma (Clinical Cancer Research) Tuesday March 1st 2016


105) Targeting the MDM2:p53 Axis in DDLPS (Clinical Cancer Research) Tuesday March 1st 2016


106) Targeting of BCL2 Proteins in Diffuse Large B-Cell Lymphoma (Clinical Cancer Research) Tuesday March 1st 2016


107) ESR1 Mutations in Advanced Breast Cancer (Clinical Cancer Research) Tuesday March 1st 2016


108) In Vivo Detection of Succinate in Paraganglioma (Clinical Cancer Research) Tuesday March 1st 2016


109) rs966423-Related Mortality in Patients with Thyroid Cancer (Clinical Cancer Research) Tuesday March 1st 2016


110) T790M by Tumor Biopsy versus Blood-Based Analyses (Clinical Cancer Research) Tuesday March 1st 2016


111) Ralimetinib for Advanced Cancer (Clinical Cancer Research) Tuesday March 1st 2016


112) Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer (Clinical Cancer Research) Tuesday March 1st 2016


113) Metformin in Pancreatic Cancer (Clinical Cancer Research) Tuesday March 1st 2016


114) A Phase II Study of AZD6244 in Multiple Myeloma (Clinical Cancer Research) Tuesday March 1st 2016


115) Abexinostat in Mantle Cell and Follicular Lymphoma (Clinical Cancer Research) Tuesday March 1st 2016


116) New Life for Immunotoxin Cancer Therapy (Clinical Cancer Research) Tuesday March 1st 2016


117) T-VEC for Cancer (Clinical Cancer Research) Tuesday March 1st 2016


118) Classical Myeloproliferative Neoplasms: New Insights (Clinical Cancer Research) Tuesday March 1st 2016


119) ESR1 Mutations in Breast Cancer (Clinical Cancer Research) Tuesday March 1st 2016


120) Metformin and Pancreatic Cancer Survival (Clinical Cancer Research) Tuesday March 1st 2016


121) Targeting mTOR Mutations in Melanoma (Clinical Cancer Research) Monday February 15th 2016


122) High-Grade Progression of Neuroendocrine Tumors (Clinical Cancer Research) Monday February 15th 2016


123) Pharmacodynamic Monitoring of Proapoptotic Drugs (Clinical Cancer Research) Monday February 15th 2016


124) ESR1 Mutations Detected in Circulating Tumor DNA (Clinical Cancer Research) Monday February 15th 2016


125) DNA Methylation on Benign Biopsy as a Prostate Cancer Marker (Clinical Cancer Research) Monday February 15th 2016


126) RhoA in Diffuse Gastric Cancer Stem-Like Cells (Clinical Cancer Research) Monday February 15th 2016


127) Image-Guided Interventions of Head and Neck Cancer (Clinical Cancer Research) Monday February 15th 2016


128) Crizotinib and Chemotherapy Synergize in Neuroblastoma (Clinical Cancer Research) Monday February 15th 2016


129) MEK Inhibition Restores Response to ER Blockade in HGSOC (Clinical Cancer Research) Monday February 15th 2016


130) Cabozantinib Inhibition Is Effective against TNBC (Clinical Cancer Research) Monday February 15th 2016


131) Targeted NGS of Cell-Free DNA from Advanced NSCLC (Clinical Cancer Research) Monday February 15th 2016


132) HAGE, a Promising Target in Triple-Negative Breast Cancer (Clinical Cancer Research) Monday February 15th 2016


133) Survival of TNBC Patients in the HIBCRIT-1 Study (Clinical Cancer Research) Monday February 15th 2016


134) Nivolumab in Metastatic Melanoma: irAE Relation to Survival (Clinical Cancer Research) Monday February 15th 2016


135) Lumretuzumab in Solid Tumors (Clinical Cancer Research) Monday February 15th 2016


136) Phase I Trial of RG7112 in Leukemia (Clinical Cancer Research) Monday February 15th 2016


137) Pharmacodynamics of the Anti-TWEAK mAb RG7212 (Clinical Cancer Research) Monday February 15th 2016


138) Phase I Study of Pevonedistat in Advanced Solid Tumors (Clinical Cancer Research) Monday February 15th 2016


139) Imatinib in Metastatic Dermatofibrosarcoma Protuberans (Clinical Cancer Research) Monday February 15th 2016


140) Safety of VX15/2503 in Patients with Advanced Solid Tumors (Clinical Cancer Research) Monday February 15th 2016


141) FCGR Polymorphisms Not Predictive in Follicular Lymphoma (Clinical Cancer Research) Monday February 15th 2016


142) MSI Frequency in Cancer (Clinical Cancer Research) Monday February 15th 2016


143) Neoantigens and Immunotherapy (Clinical Cancer Research) Monday February 15th 2016


144) Targeting Reawakening of Cancer Stem Cells (Clinical Cancer Research) Monday February 15th 2016


145) Bladder Cancer Immunotherapy (Clinical Cancer Research) Monday February 15th 2016


146) Expanded Profiling of ctDNA in Lung Cancer (Clinical Cancer Research) Monday February 15th 2016


147) Significance of Fc{gamma}RIIIa-V158F Polymorphism (Clinical Cancer Research) Monday February 15th 2016


148) Small RNAs as Novel Biomarkers in Colorectal Cancer (Clinical Cancer Research) Sunday January 31st 2016


149) Stress-Related Signaling and Lethal Prostate Cancer (Clinical Cancer Research) Sunday January 31st 2016


150) The CSF3R T640N Mutation Mimics T618I (Clinical Cancer Research) Sunday January 31st 2016


151) p53-KLF4-CEBPA Axis in AML (Clinical Cancer Research) Sunday January 31st 2016


152) Non-EMT Features Predict Colorectal Cancer Metastasis (Clinical Cancer Research) Sunday January 31st 2016


153) MYBL1-NFIB Fusions in Adenoid Cystic Carcinoma (Clinical Cancer Research) Sunday January 31st 2016


154) CD27+ TIL in High-Grade Serous Ovarian Cancer (Clinical Cancer Research) Sunday January 31st 2016


155) PD-L1 Expression and TILs in HNSCC (Clinical Cancer Research) Sunday January 31st 2016


156) STAT3{beta} Dictates the Opposing Function of STAT3 in ESCC (Clinical Cancer Research) Sunday January 31st 2016


157) NKTR-214, an Engineered Cytokine for Cancer Immunotherapy (Clinical Cancer Research) Sunday January 31st 2016


158) Prostate Cancer Stem Cell Therapy (Clinical Cancer Research) Sunday January 31st 2016


159) Local HPV Vaccinia Boost Enhances T-cell Responses (Clinical Cancer Research) Sunday January 31st 2016


160) Therapeutic Wnt Pathway Inhibition in Colorectal Cancer (Clinical Cancer Research) Sunday January 31st 2016


161) Pan-HER Augments Radiation Response (Clinical Cancer Research) Sunday January 31st 2016


162) BEZ235 plus Dexamethasone in ALL (Clinical Cancer Research) Sunday January 31st 2016


163) Pan-Cancer EMT Molecular and Immune Alterations (Clinical Cancer Research) Sunday January 31st 2016


164) ALT-803 Enhances NK-Cell Antilymphoma Responses (Clinical Cancer Research) Sunday January 31st 2016


165) Immune Characterization of Murine Medulloblastoma Subtypes (Clinical Cancer Research) Sunday January 31st 2016


166) Response Assessment of Recurrent Glioblastoma Patients (Clinical Cancer Research) Sunday January 31st 2016


167) Prognostic Value of BRAF Mutation Detection in Circulation (Clinical Cancer Research) Sunday January 31st 2016


168) Prosigna ROR Score Predicts Chemosensitivity (Clinical Cancer Research) Sunday January 31st 2016


169) Toxicity Attribution in Phase I Trials (Clinical Cancer Research) Sunday January 31st 2016


170) ALK in Pediatric Cancer (Clinical Cancer Research) Sunday January 31st 2016


171) Mitochondrial Control of Tumor Progression (Clinical Cancer Research) Sunday January 31st 2016


172) How HIPAA Regulation Changes Affect Research (Clinical Cancer Research) Sunday January 31st 2016


173) Local Tumor Immunity and Cancer Vaccine (Clinical Cancer Research) Sunday January 31st 2016


174) Measuring Toxicity in Phase I Clinical Trials (Clinical Cancer Research) Sunday January 31st 2016


175) Angiotensin System Inhibitors in Renal Cell Carcinoma--Letter (Clinical Cancer Research) Friday January 15th 2016


176) Prognostic Model for Early-Stage Endometrioid Carcinoma (Clinical Cancer Research) Friday January 15th 2016


177) Regulation of HCC Differentiation by KLF4/HNF-6 (Clinical Cancer Research) Friday January 15th 2016


178) MDSCs Accumulate around SMAD4-CRC through the CCL15-CCR1 Axis (Clinical Cancer Research) Friday January 15th 2016


179) SRC3-pS543 in ER-Positive Breast Cancer (Clinical Cancer Research) Friday January 15th 2016


180) PD-L1 and HLA Class I in Intrahepatic Cholangiocarcinoma (Clinical Cancer Research) Friday January 15th 2016


181) Wnt-5 in CLL Pathogenesis (Clinical Cancer Research) Friday January 15th 2016


182) Germline ASPN Variants and Metastatic Progression (Clinical Cancer Research) Friday January 15th 2016


183) PD1 Blockade Augments TCR-Engineered Adoptive T-cell Therapy (Clinical Cancer Research) Friday January 15th 2016


184) Afatinib + Cetuximab First-line in EGFR-Mutant Lung Cancer (Clinical Cancer Research) Friday January 15th 2016


185) Stromal Depletion by Minnelide in Pancreatic Cancer (Clinical Cancer Research) Friday January 15th 2016


186) Targeting MEK and CDK4/6 in KRAS-Mutant Colorectal Cancers (Clinical Cancer Research) Friday January 15th 2016


187) Inhibition of Exosomal Drug Export by Indomethacin (Clinical Cancer Research) Friday January 15th 2016


188) Combination of 5T4-ADC with PI3K/mTOR Inhibitors or Taxanes (Clinical Cancer Research) Friday January 15th 2016


189) Copy Number Associated with Clinical Outcome in Melanoma (Clinical Cancer Research) Friday January 15th 2016


190) Exome Sequencing and Gemcitabine/Carboplatin Toxicity (Clinical Cancer Research) Friday January 15th 2016


191) Biopsy Guidance by Diffuse Reflectance Spectroscopy (Clinical Cancer Research) Friday January 15th 2016


192) TIL Predict Immunotherapy Outcome (Clinical Cancer Research) Friday January 15th 2016


193) Breast Cancer Outcome Prediction after Standard Treatment (Clinical Cancer Research) Friday January 15th 2016


194) CXCL13 Predicts Response to Treatment of AIDS-NHL (Clinical Cancer Research) Friday January 15th 2016


195) Imatinib or Rituximab for Cutaneous Sclerosis Chronic GVHD (Clinical Cancer Research) Friday January 15th 2016


196) LMB-2/FC in Adult T-cell Leukemia (Clinical Cancer Research) Friday January 15th 2016


View: prev | next


Mitch Andre Garcia's Chem Feeds 2008-present

Some images have been reproduced by permission of The Royal Society of Chemistry. (RSC' RSS Policy)
Other images have been reproduced with permission of the American Chemical Society. (ACS' RSS Policy)
Few images have been reproduced with pending permission of Wiley-VCH. ()